Complementation between kinase‐defective and activation‐defective TGF‐beta receptors reveals a novel form of receptor cooperativity essential for signaling.

Transforming growth factor‐beta (TGF‐beta) signals through two transmembrane serine/threonine kinases, T beta R‐I and T beta R‐II. TGF‐beta binds to T beta R‐II, allowing this receptor to associate with and phosphorylate T beta R‐I which then propagates the signal. T beta R‐I is phosphorylated within its GS domain, a region immediately preceding the kinase domain. To further understand the function of T beta R‐I in this complex, we analyzed T beta R‐I‐inactivating mutations identified in cell lines that are defective in TGF‐beta signaling yet retain ligand binding ability. The three mutations identified here all fall in the kinase domain of T beta R‐I. One mutation disrupts the kinase activity of T beta R‐I, whereas the other two mutations prevent ligand‐induced T beta R‐I phosphorylation, and thus activation, by T beta R‐II. Unexpectedly, a kinase‐defective T beta R‐I mutant can functionally complement an activation‐ defective T beta R‐I mutant, by rescuing its T beta R‐II‐ dependent phosphorylation. Together with evidence that the ligand‐induced receptor complex contains two or more T beta R‐I molecules, these results support a model in which the kinase domain of one T beta R‐I molecule interacts with the GS domain of another, enabling its phosphorylation and activation by T beta R‐II. This cooperative interaction between T beta R‐I molecules appears essential for TGF‐beta signal transduction.

[1]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[2]  J. Massagué,et al.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. , 1989, The Journal of biological chemistry.

[3]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[4]  J. Massagué,et al.  Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. , 1990, The Journal of biological chemistry.

[5]  K. Miyazono,et al.  Receptors for transforming growth factor-beta. , 1994, Advances in immunology.

[6]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[7]  J. Massagué,et al.  Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex , 1995, Molecular and cellular biology.

[8]  D. Riddle,et al.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. , 1994, The Journal of biological chemistry.

[9]  R Wieser,et al.  Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region , 1993, Molecular and cellular biology.

[10]  J. Zheng,et al.  Structural framework for the protein kinase family. , 1992, Annual review of cell biology.

[11]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[12]  J. Massagué,et al.  Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin , 1994, Molecular and cellular biology.

[13]  A. Liss The TGF-(3 family and its composite receptors , 1994 .

[14]  T. Taniguchi Cytokine signaling through nonreceptor protein tyrosine kinases. , 1995, Science.

[15]  M. Affolter,et al.  An absolute requirement for both the type II and type I receptors, punt and thick veins, for Dpp signaling in vivo , 1995, Cell.

[16]  J. Smith,et al.  Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects , 1995, The Journal of cell biology.

[17]  M. Laiho,et al.  Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. , 1987, The Journal of biological chemistry.

[18]  Sung-Hou Kim,et al.  Crystal structure of cyclin-dependent kinase 2 , 1993, Nature.

[19]  R. Derynck,et al.  Phosphorylation-dependent Interaction of the Cytoplasmic Domains of the Type I and Type II Transforming Growth Factor- Receptors (*) , 1995, The Journal of Biological Chemistry.

[20]  R. Weinberg,et al.  Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Russell,et al.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. , 1993, The EMBO journal.

[22]  J. Massagué,et al.  Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. , 1990, The Journal of biological chemistry.

[23]  H. Lodish,et al.  Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Miyazono,et al.  Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. , 1994, The Journal of biological chemistry.

[25]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[26]  R. Mulligan,et al.  Two dominant-acting selectable markers for gene transfer studies in mammalian cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[28]  R. Derynck,et al.  Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. , 1993, Science.

[29]  Susan S. Taylor,et al.  Three protein kinase structures define a common motif. , 1994, Structure.

[30]  J. Massagué,et al.  Reconstitution and transphosphorylation of TGF‐beta receptor complexes. , 1994, The EMBO journal.

[31]  J. Massagué,et al.  Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II. , 1991, The Journal of biological chemistry.

[32]  J. Miller,et al.  Determination of DNA sequence changes induced by ethyl methanesulfonate in human cells, using a shuttle vector system , 1986, Molecular and cellular biology.

[33]  K. Miyazono,et al.  Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.

[34]  J. Massagué,et al.  The TGF-β family and its composite receptors , 1994 .

[35]  J. Massagué,et al.  Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex , 1994, Molecular and cellular biology.

[36]  S. Hubbard,et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.

[37]  M. L. Gustafson,et al.  A transforming growth factor beta type I receptor that signals to activate gene expression. , 1994, Science.

[38]  J. Massagué,et al.  The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors , 1987, Cell.

[39]  Elizabeth J. Goldsmith,et al.  Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution , 1994, Nature.

[40]  J. Massagué,et al.  Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.

[41]  K. Miyazono,et al.  Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.

[42]  J. Massagué,et al.  GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.

[43]  W. Gelbart,et al.  Drosophila Dpp signaling is mediated by the punt gene product: A dual ligand-binding type II receptor of the TGFβ receptor family , 1995, Cell.

[44]  H. Lodish,et al.  Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases. , 1993, Trends in cell biology.

[45]  J. Massagué,et al.  Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.